Laboratory Corporation of America Holdings (0JSY.L)

USD 225.29

(1.26%)

Long Term Debt Summary of Laboratory Corporation of America Holdings

  • Laboratory Corporation of America Holdings's latest annual long term debt in 2023 was 4.05 Billion USD , down -30.12% from previous year.
  • Laboratory Corporation of America Holdings's latest quarterly long term debt in 2024 Q1 was 3.04 Billion USD , down -0.01% from previous quarter.
  • Laboratory Corporation of America Holdings reported annual long term debt of 5.8 Billion USD in 2022, down -5.56% from previous year.
  • Laboratory Corporation of America Holdings reported annual long term debt of 6.14 Billion USD in 2021, down -0.61% from previous year.
  • Laboratory Corporation of America Holdings reported quarterly long term debt of 3.04 Billion USD for 2024 Q1, down -0.01% from previous quarter.
  • Laboratory Corporation of America Holdings reported quarterly long term debt of 4.05 Billion USD for 2023 Q3, down -21.58% from previous quarter.

Annual Long Term Debt Chart of Laboratory Corporation of America Holdings (2023 - 1989)

Historical Annual Long Term Debt of Laboratory Corporation of America Holdings (2023 - 1989)

Year Long Term Debt Long Term Debt Growth
2023 4.05 Billion USD -30.12%
2022 5.8 Billion USD -5.56%
2021 6.14 Billion USD -0.61%
2020 6.18 Billion USD -4.34%
2019 6.46 Billion USD 6.94%
2018 6.04 Billion USD -4.77%
2017 6.34 Billion USD 19.71%
2016 5.3 Billion USD -11.55%
2015 5.99 Billion USD 123.36%
2014 2.68 Billion USD -10.15%
2013 2.98 Billion USD 12.46%
2012 2.65 Billion USD 27.31%
2011 2.08 Billion USD 14.17%
2010 1.82 Billion USD 86.93%
2009 977.2 Million USD -38.94%
2008 1.6 Billion USD 48.54%
2007 1.07 Billion USD 78.69%
2006 603 Million USD -0.25%
2005 604.5 Million USD -32.25%
2004 892.2 Million USD 147.35%
2003 360.7 Million USD -30.83%
2002 521.5 Million USD 2.48%
2001 508.9 Million USD 43.88%
2000 353.7 Million USD -26.74%
1999 482.8 Million USD -16.11%
1998 575.5 Million USD -16.55%
1997 689.6 Million USD -45.34%
1996 1.26 Billion USD 34.2%
1995 940.1 Million USD 66.74%
1994 563.8 Million USD 88.44%
1993 299.2 Million USD 253.66%
1992 84.6 Million USD 0.0%
1991 - USD -100.0%
1990 22 Million USD 0.0%
1989 - USD 0.0%

Peer Long Term Debt Comparison of Laboratory Corporation of America Holdings

Name Long Term Debt Long Term Debt Difference
Phreesia, Inc. 2.04 Million USD -197786.774%
Accuray Incorporated 164.4 Million USD -2366.363%
Align Technology, Inc. 96.96 Million USD -4081.483%
Elevance Health Inc. 23.24 Billion USD 82.557%
AxoGen, Inc. 46.6 Million USD -8600.513%
Boston Scientific Corporation 8.56 Billion USD 52.665%
CVS Health Corporation 74.67 Billion USD 94.57%
Cardinal Health, Inc. 4.58 Billion USD 11.527%
Centene Corporation 17.69 Billion USD 77.091%
DaVita Inc. 8.05 Billion USD 49.639%
HCA Healthcare, Inc. 36.62 Billion USD 88.93%
Hologic, Inc. 2.49 Billion USD -62.376%
Humana Inc. 10.21 Billion USD 60.299%
IDEXX Laboratories, Inc. 622.88 Million USD -550.957%
Masimo Corporation 871.7 Million USD -365.149%
McKesson Corporation 5.45 Billion USD 25.615%
Patterson Companies, Inc. 328.91 Million USD -1132.765%
Quest Diagnostics Incorporated 4.41 Billion USD 8.057%
ResMed Inc. 697.31 Million USD -481.475%
Henry Schein, Inc. 1.93 Billion USD -109.762%
Teladoc Health, Inc. 1.58 Billion USD -156.379%
Universal Health Services, Inc. 4.71 Billion USD 14.025%
Veeva Systems Inc. 46.44 Million USD -8630.863%
Baxter International Inc. 11.06 Billion USD 63.352%
Becton, Dickinson and Company 14.73 Billion USD 72.488%
Intuitive Surgical, Inc. -82.1 Million USD 5038.733%
Danaher Corporation 17.66 Billion USD 77.042%
Stryker Corporation 10.9 Billion USD 62.804%
Medtronic plc 23.87 Billion USD 83.018%